T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Roper Technologies
ROP
|
$795M |
| 2 |
Abbott
ABT
|
$750M |
| 3 |
Thermo Fisher Scientific
TMO
|
$746M |
| 4 |
Becton Dickinson
BDX
|
$730M |
| 5 |
Cigna
CI
|
$725M |
Top Sells
| 1 |
Salesforce
CRM
|
$1.32B |
| 2 |
Martin Marietta Materials
MLM
|
$959M |
| 3 |
Linde
LIN
|
$839M |
| 4 |
AbbVie
ABBV
|
$829M |
| 5 |
Intercontinental Exchange
ICE
|
$814M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 20.82% |
| 3 | Consumer Discretionary | 12.47% |
| 4 | Industrials | 10.66% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Eli Lilly
LLY
$653B
| $610M | 0.38% |
790,778
+14,927
| +2% | +$11.5M |
|
77
Teledyne Technologies
TDY
$24.9B
| $609M | 0.38% |
1,313,061
-209,673
| -14% | -$97.3M |
|
78
Reddit
RDDT
$41.3B
| $602M | 0.37% |
3,684,178
-365,090
| -9% | -$59.7M |
|
79
JB Hunt Transport Services
JBHT
$13.9B
| $596M | 0.37% |
3,493,695
-1,801,933
| -34% | -$308M |
|
|
80
Intercontinental Exchange
ICE
$100B
| $576M | 0.36% |
3,865,597
-5,459,619
| -59% | -$814M |
|
81
Broadridge
BR
$29.8B
| $564M | 0.35% |
2,495,407
-167,692
| -6% | -$37.9M |
|
82
Range Resources
RRC
$8.18B
| $558M | 0.34% |
15,507,616
-317,483
| -2% | -$11.4M |
|
83
Bright Horizons
BFAM
$6.59B
| $550M | 0.34% |
4,958,538
+1,868,117
| +60% | +$207M |
|
84
Advanced Micro Devices
AMD
$260B
| $543M | 0.34% |
4,497,954
-1,696,101
| -27% | -$205M |
|
85
Alcon
ALC
$38.7B
| $541M | 0.33% |
6,368,453
-21,860
| -0.3% | -$1.86M |
|
86
Broadcom
AVGO
$1.39T
| $531M | 0.33% |
2,289,753
-59,161
| -3% | -$13.7M |
|
87
Keysight
KEYS
$27.7B
| $527M | 0.33% |
3,283,882
-827,421
| -20% | -$133M |
|
88
Toast
TOST
$25.5B
| $526M | 0.32% |
14,437,402
-233,109
| -2% | -$8.5M |
|
89
Zoom
ZM
$24B
| $521M | 0.32% |
6,385,523
+1,247,717
| +24% | +$102M |
|
90
Spotify
SPOT
$141B
| $520M | 0.32% |
1,163,193
-119,613
| -9% | -$53.5M |
|
91
MarketAxess Holdings
MKTX
$6.81B
| $520M | 0.32% |
2,298,409
+236,118
| +11% | +$53.4M |
|
92
Cytokinetics
CYTK
$5.78B
| $506M | 0.31% |
10,752,123
+1,062,136
| +11% | +$50M |
|
93
New York Times
NYT
$9.6B
| $505M | 0.31% |
9,694,544
-552,550
| -5% | -$28.8M |
|
94
QuidelOrtho
QDEL
$1.89B
| $501M | 0.31% |
11,238,826
+1,840,667
| +20% | +$82M |
|
95
Ionis Pharmaceuticals
IONS
$8.95B
| $495M | 0.31% |
14,169,199
+1,083
| +0% | +$37.9K |
|
|
96
Salesforce
CRM
$239B
| $480M | 0.3% |
1,435,357
-3,937,212
| -73% | -$1.32B |
|
97
Pinnacle Financial Partners
PNFP
$7.43B
| $477M | 0.29% |
4,168,156
-178,036
| -4% | -$20.4M |
|
98
Liberty Live Group Series C
LLYVK
$8.85B
| $474M | 0.29% |
6,968,861
+1,427,968
| +26% | +$97.2M |
|
99
Biogen
BIIB
$20.2B
| $474M | 0.29% |
3,099,786
-1,156,500
| -27% | -$177M |
|
100
CoStar Group
CSGP
$37.5B
| $459M | 0.28% |
6,415,895
+1,267,263
| +25% | +$90.7M |
|